(Q40055099)

16 September 2017

title

Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials (English)

1 reference

16 September 2017

0 references

Abdo A Elfiky

1

0 references

language of work or name

1 reference

7 September 2016

1 reference

Journal of Medical Virology

16 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

16 September 2017

volume

88

1 reference

16 September 2017

issue

12

1 reference

16 September 2017

page(s)

2044-2051

1 reference

on focus list of Wikimedia project

16 September 2017

WikiProject Zika Corpus

0 references

cites work

Daclatasvir plus sofosbuvir for HCV infection: an oral combination therapy with high antiviral efficacy

1 reference

Characterization of NS3 protease from an Egyptian HCV genotype 4a isolate

21 January 2018

1 reference

Water Determines the Structure and Dynamics of Proteins

21 January 2018

1 reference

A simple technique for infection of mosquitoes with viruses; transmission of Zika virus

21 January 2018

1 reference

Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors

21 January 2018

1 reference

Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus

21 January 2018

1 reference

Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase.

21 January 2018

1 reference

Zika virus. I. Isolations and serological specificity

21 January 2018

1 reference

Zika Virus Outbreak on Yap Island, Federated States of Micronesia

21 January 2018

1 reference

IDX-184 is a superior HCV direct-acting antiviral drug: a QSAR study

21 January 2018

1 reference

Molecular modeling comparison of the performance of NS5b polymerase inhibitor (PSI-7977) on prevalent HCV genotypes

21 January 2018

1 reference

2′-Methylguanosine Prodrug (IDX-184), Phosphoramidate Prodrug (Sofosbuvir), Diisobutyryl Prodrug (R7128) Are Better Than Their Parent Nucleotides and Ribavirin in Hepatitis C Virus Inhibition: A Molecular Modeling Study

21 January 2018

1 reference

Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis

21 January 2018

1 reference

New approaches in the treatment of hepatitis C

21 January 2018

1 reference

Zika virus in Gabon (Central Africa)--2007: a new threat from Aedes albopictus?

21 January 2018

1 reference

Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage

21 January 2018

1 reference

Hepatitis C virus resistance to protease inhibitors

21 January 2018

1 reference

The Phyre2 web portal for protein modeling, prediction and analysis

21 January 2018

1 reference

Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses

21 January 2018

1 reference

Two cases of Zika fever imported from French Polynesia to Japan, December 2013 to January 2014

21 January 2018

1 reference

Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007

21 January 2018

1 reference

Development of novel therapies for hepatitis C.

21 January 2018

1 reference

The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site

21 January 2018

1 reference

Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria

21 January 2018

1 reference

Zika Virus Associated with Microcephaly

21 January 2018

1 reference

Rapid spread of emerging Zika virus in the Pacific area

21 January 2018

1 reference

Zika virus, a cause of fever in Central Java, Indonesia

21 January 2018

1 reference

Deciphering key features in protein structures with the new ENDscript server

21 January 2018

1 reference

The Electronic and Quantitative Structure Activity Relationship Properties of Modified Telaprevir Compounds as HCV NS3 Protease Inhibitors

21 January 2018

1 reference

Theoretical Study on Modified Boceprevir Compounds as NS3 Protease Inhibitors

21 January 2018

1 reference

Antiviral strategies in hepatitis C virus infection

21 January 2018

1 reference

Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega

21 January 2018

1 reference

Structural properties of metal-free apometallothioneins

21 January 2018

1 reference

New developments in small molecular compounds for anti-hepatitis C virus (HCV) therapy

21 January 2018

1 reference

Anti-HCV drugs in the pipeline

21 January 2018

1 reference

Zika virus outbreak and the case for building effective and sustainable rapid diagnostics laboratory capacity globally

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.24678

1 reference

16 September 2017

1 reference